Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
SGI Breakthrough Technology Empowers Genome Center Research Around the World
May 18th, 2008
BIO-IT WORLD CONFERENCE AND EXPO 2008, Booth 306/308 -- As scientists seek to accelerate sequencing genomes of varied arrays of organisms from fish parasites to cancer cells in an effort to determine causes and cures of diseases that plague mankind, breakthrough technology from SGI (NASDAQ:SGIC) is powering research in genome centers around the world. Leading institutions, including the Translational Genomics Research Institute in Phoenix, Ariz., the Malaysia Genome Institute in Selangor and the China National Human Genome Center in Shanghai, have turned to SGI(R) high-performance computing and storage solutions to create an optimal workflow for faster time to discovery....
Source: Medical Letter on the CDC & FDA (2008-05-18)
|
